Zambon Taps Kinaxis to Enhance Transparency Across Global Supply Chain
23 September 2024 - 9:00PM
Business Wire
Italian multinational pharmaceutical company
seeks to gain clarity amid complexity following product portfolio
expansion
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply
chain orchestration, today announced Zambon, a multinational
pharmaceutical company committed to innovating cure and care to
make patients’ lives better, has selected Kinaxis to help
orchestrate full visibility and transparency across its vast global
supply chain.
With 23 subsidiaries, a product presence in 87 countries and
manufacturing facilities spread across three continents, the
complexity of the Italian-headquartered company’s supply chain
requires a unique approach to balance its supply and demand.
Alongside its three historical therapeutic areas of focus
targeting respiratory system diseases, urinary tract infections and
pain management, Zambon has expanded its portfolio in recent years
by introducing important treatments for Parkinson’s, Cystic
Fibrosis and developing a pipeline focused on rare diseases such as
Bronchiolitis Obliterans Syndrome (BOS) and Non–Cystic Fibrosis
Bronchiectasis (NCFB). Each of which involves a high-touch approach
to adequately balance production resources and inventory levels
based on distinct logistics parameters including lead times and
safety stock. Kinaxis Maestro™, the only AI-infused supply chain
orchestration platform, will enable the pharmaceutical company to
refine its sales and operations planning processes and gain a
better handle on its supply chain, even during periods of demand
volatility or disruption.
“We’re thrilled to be working with Kinaxis to help us streamline
our supply chain processes and boost visibility across the entirety
of our global operations,” said Andrea Paganelli, chief global
industrial business operations at Zambon. “For over a hundred
years, we’ve been guided by an ongoing commitment and
responsibility to take care of people’s health and this investment
continues in that tradition so that our essential prescription
drugs are efficiently distributed to patients when and where they
need them.”
“With a dizzying array of stakeholders including manufacturers,
distributors, wholesalers, regulators, doctors and pharmacies, drug
supply chains are about as complex as they come,” said Fabienne
Cetre, executive vice president, EMEA sales at Kinaxis.
“Despite these challenges, savvy leaders like Zambon know that a
stable future where patients can consistently access their
medications is possible and with Kinaxis, they can make more
informed decisions about their business while proactively managing
risks from unforeseen disruptions.”
With the addition of Zambon to its growing customer base,
Kinaxis continues to cement its footprint within the life sciences
industry, which provides the brand-name and generic medicines that
countless patients rely on. Managing supply chain complexities in
biotechnology, cell and gene therapy, medical devices,
over-the-counter medicines and more, Kinaxis customers include some
of the world's top pharma companies such as Dr. Reddy's, Jamieson
Wellness, Merck, Novartis, Siemens Healthineers and Servier.
Kinaxis’ AI-powered software allows companies to orchestrate
their supply chain network end to end, from strategic planning to
last-mile delivery. Kinaxis’ technology helps companies that supply
the agricultural industry with 40% of the world’s tractors, that
keep more than 110 billion teeth clean each year, and that ensures
more than 35 million pets are fed nutritious meals each year.
To learn more about Kinaxis and its supply chain management
solutions, please visit Kinaxis.com.
About Kinaxis Kinaxis is a global leader in modern supply
chain orchestration, powering complex global supply chains and
supporting the people who manage them, in service of humanity. Our
powerful, AI-infused supply chain orchestration platform, Maestro™
, combines proprietary technologies and techniques that provide
full transparency and agility across the entire supply chain — from
multi-year strategic planning to last-mile delivery. We are trusted
by renowned global brands to provide the agility and predictability
needed to navigate today’s volatility and disruption. For more news
and information, please visit kinaxis.com or follow us on
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240923380059/en/
Media Relations Jaime Cook | Kinaxis jcook@kinaxis.com
289-552-4640
Investor Relations Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com 613-907-7613
Kinaxis (TSX:KXS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Kinaxis (TSX:KXS)
Historical Stock Chart
From Oct 2023 to Oct 2024